Advertisement
Advertisement
INDV
Indivior Pharmaceuticals, Inc. Common Stock
37.46
USDSponsored
-0.13
-0.35%
May 21, 16:00 UTC -4
Closed
After-Market
37.42
-0.04
-0.09%
INDV Earnings Reports
Positive Surprise Ratio
INDV beat 14 of 21 last estimates.
67%
Next Report
Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
$312.68M
/$0.88
Implied change from Q1 26 (Revenue/ EPS)
-1.36%
/-8.33%
Implied change from Q2 25 (Revenue/ EPS)
+3.54%
/+72.55%
Indivior Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On Apr 30, 2026, INDV reported earnings of 0.96 USD per share (EPS) for Q1 26, beating the estimate of 0.66 USD, resulting in a 43.69% surprise. Revenue reached 317.00 million, compared to an expected 278.30 million, with a 13.91% difference. The market reacted with a +7.70% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of 0.88 USD, with revenue projected to reach 312.68 million USD, implying an decrease of -8.33% EPS, and decrease of -1.36% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ARS Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.53
Actual
-$0.61
Surprise
-13.81%
ProKidney Corp. Class A Ordinary Shares
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+0.57%
Galectin Therapeutics Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.08
Surprise
-30.72%
NRX Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
$0.29
Actual
-$0.04
Surprise
-113.64%
Incannex Healthcare Limited - ADR
Report Date
May 15, 2026 For Q3 26
Estimate
-$0.94
Actual
-$11.22
Surprise
-1088.38%
VYNE Therapeutics Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.08
Surprise
+56.43%
Wellgistics Health, Inc. Common Stock
Report Date
May 19, 2026 For Q1 26
Estimate
-Actual
-$0.07
Surprise
-
Traws Pharma, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.75
Actual
-$0.53
Surprise
+29.78%
60 Degrees Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.77
Actual
-$1.28
Surprise
-65.12%
AIM ImmunoTech Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.37
Actual
-$0.56
Surprise
-52.53%
FAQ
What were Indivior Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Indivior Pharmaceuticals, Inc. Common Stock reported EPS of $0.96, beating estimates by 43.69%, and revenue of $317.00M, 13.91% above expectations.
How did the market react to Indivior Pharmaceuticals, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 7.7%, changed from $34.15 before the earnings release to $36.78 the day after.
When is Indivior Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for Jul 29, 2026.
What are the forecasts for Indivior Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 5
analysts, Indivior Pharmaceuticals, Inc. Common Stock is expected to report EPS of $0.88 and revenue of $312.68M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement